LEADER 03946nam 22007095 450 001 9910298452103321 005 20200702052718.0 010 $a3-319-23213-4 024 7 $a10.1007/978-3-319-23213-3 035 $a(CKB)3710000000532692 035 $a(EBL)4199769 035 $a(SSID)ssj0001596854 035 $a(PQKBManifestationID)16297931 035 $a(PQKBTitleCode)TC0001596854 035 $a(PQKBWorkID)14886019 035 $a(PQKB)10946267 035 $a(DE-He213)978-3-319-23213-3 035 $a(MiAaPQ)EBC4199769 035 $a(PPN)19088584X 035 $a(EXLCZ)993710000000532692 100 $a20151212d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aBeneficial Microorganisms in Medical and Health Applications /$fedited by Min-Tze Liong 205 $a1st ed. 2015. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2015. 215 $a1 online resource (266 p.) 225 1 $aMicrobiology Monographs,$x1862-5576 ;$v28 300 $aDescription based upon print version of record. 311 $a3-319-23212-6 320 $aIncludes bibliographical references and index. 327 $aHealth effects of pro- & prebiotics ? utilization of sophisticated in vitro tools -- In vitro and in vivo inhibition of atopic dermatitis (AD) by a novel probiotic isolate Lactobacillus sakei Probio 65 -- Bifidobacterium for infants: Essence and efficacy -- Roles of omics in targetting microbial health potentials -- Immune modulation by probiotics -- Efficacy of probiotics in prevention of influenza -- Gut commensal microbes and mucosal immune systems -- Production of hepatitis B vaccines by beneficial microorganisms -- Effects of  SCFA  producing gut microbiota on the epigenetic regulation of inflammation -- Bacteriocin from LAB for medical & health applications -- Gut microbiome & stress. 330 $aThis volume is devoted to the application of microorganisms in medical treatment and health protection. Topics discussed include the role of probiotics in immune modulation, in prevention of influenza, and in atopic dermatitis. Further chapters cover aspects such as the relation of the gut microbiome and stress, the immune system, the regulation of inflammation, the benefits of Bifidobacterium for infants, and bacteriocin in medical applications, as well as the use of in vitro models of the gastrointestinal tract, omics approaches for targeting microbial health potential and the production of hepatitis B vaccines. This volume will be of particular interest to scientists working in the fields of clinical medicine, applied microbiology, pharmacy and public health. 410 0$aMicrobiology Monographs,$x1862-5576 ;$v28 606 $aMicrobiology 606 $aMedical microbiology 606 $aNutrition    606 $aMedical research 606 $aMicrobiology$3https://scigraph.springernature.com/ontologies/product-market-codes/L23004 606 $aMedical Microbiology$3https://scigraph.springernature.com/ontologies/product-market-codes/B16003 606 $aNutrition$3https://scigraph.springernature.com/ontologies/product-market-codes/C18000 606 $aQuality of Life Research$3https://scigraph.springernature.com/ontologies/product-market-codes/H65000 615 0$aMicrobiology. 615 0$aMedical microbiology. 615 0$aNutrition   . 615 0$aMedical research. 615 14$aMicrobiology. 615 24$aMedical Microbiology. 615 24$aNutrition. 615 24$aQuality of Life Research. 676 $a579.16 702 $aLiong$b Min-Tze$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910298452103321 996 $aBeneficial Microorganisms in Medical and Health Applications$92511887 997 $aUNINA